Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) announced that it has filed a Certificate of Amendment to its Amended and Restated Certificate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE